American Healthcare REIT (NYSE:AHR) Releases FY 2024 Earnings Guidance

American Healthcare REIT (NYSE:AHR) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.400-1.430 for the period, compared to the consensus earnings per share estimate of 1.280. The company issued revenue guidance of -. American Healthcare REIT also updated its FY24 guidance to $1.40-1.43 EPS.

American Healthcare REIT Stock Performance

Shares of American Healthcare REIT stock opened at $26.81 on Thursday. The business has a 50-day simple moving average of $25.16 and a 200 day simple moving average of $19.21. The firm has a market capitalization of $3.53 billion and a price-to-earnings ratio of -55.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. American Healthcare REIT has a one year low of $12.63 and a one year high of $27.77.

American Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were paid a dividend of $0.25 per share. The ex-dividend date was Friday, September 20th. This represents a $1.00 dividend on an annualized basis and a yield of 3.73%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -208.33%.

Wall Street Analyst Weigh In

AHR has been the subject of several recent research reports. Bank of America boosted their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a research report on Tuesday, September 24th. Colliers Securities upgraded American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a report on Sunday, October 13th. KeyCorp upped their price target on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, September 16th. Morgan Stanley raised their price objective on American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, August 22nd. Finally, Truist Financial upped their target price on shares of American Healthcare REIT from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $23.00.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.